9h

Pfizer opened today, with a headline that looks like a clear win and a bottom line that complicates it. The drugmaker beat Wall Street on second-quarter revenue and nudged up its full-year outlook, yet it also swung to a net loss for the quarter. Shares still rose about 2% in premarket trading, because investors focused […] The post Is Pfizer’s 6.9% dividend safe after Its Q2 earnings beat appeared first on Rolling Out .